Provided by Tiger Trade Technology Pte. Ltd.

Avis Budget

120.42
+5.815.06%
Post-market: 120.420.00000.00%17:42 EST
Volume:569.32K
Turnover:67.93M
Market Cap:4.24B
PE:-2.02
High:121.09
Open:114.44
Low:114.44
Close:114.62
52wk High:212.81
52wk Low:54.03
Shares:35.20M
Float Shares:14.77M
Volume Ratio:1.12
T/O Rate:3.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-59.6591
EPS(LYR):-51.2958
ROE:5800.00%
ROA:1.69%
PB:-1.77
PE(LYR):-2.35

Loading ...

Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy

TIPRANKS
·
Feb 05

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

GlobeNewswire
·
Feb 05

AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia

TIPRANKS
·
Feb 04

Carbon credit demand plateaued in 2025 as buyers sorted by quality, compliance and durability

Fastmarkets
·
Feb 03

These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More

Benzinga_recent_news
·
Feb 03

ASX Dividend Stocks To Consider In February 2026

Simply Wall St.
·
Feb 02

Imugene Posts Strong Azer-cel Data and Cuts Costs as It Advances Toward Pivotal Trial

TIPRANKS
·
Jan 30

CAR Group (WN6) Receives a Buy from Morgans

TIPRANKS
·
Jan 30

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

GlobeNewswire
·
Jan 28

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

GlobeNewswire
·
Jan 28

Chimeric Therapeutics Posts Strong CDH17 CAR‑T Data and Gains FDA Orphan Status for Gastric Cancer

TIPRANKS
·
Jan 28

Estimating The Fair Value Of CAR Group Limited (ASX:CAR)

Simply Wall St.
·
Jan 27

CARsgen Flags Sharp Narrowing of 2025 Losses on CAR-T Commercial Gains

TIPRANKS
·
Jan 26

How CARsgen’s Solid Tumor CAR T Virus Combo Trial Could Reshape Its Story for Investors (SEHK:2171)

Simply Wall St.
·
Jan 25

XTALPI (02228) Empowers Leman Biotech to Achieve Major Breakthrough in Cell Therapy, Achieving Complete Remission in Multiple Systemic Lupus Erythematosus Patients with CAR-T at 1‰ Dose

Stock News
·
Jan 23

Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push

TIPRANKS
·
Jan 23

Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy

TIPRANKS
·
Jan 22

WeShop Enters Into Retail Partnerships Ahead of Winter Travel Season

MT Newswires Live
·
Jan 21

KPMG and Alpaca Vietnam Form Strategic Alliance to Deploy Basel III Solutions in Compliance with Circular No. 14/2025/TT-NHNN

prnewswire
·
Jan 21

Avis Budget Group Inc. to Announce Fourth Quarter 2025 Results and Host Investor Call

Reuters
·
Jan 16